STOCK TITAN
  1. Home
  2. Sec-filings
  3. CRWV
  4. [144] CoreWeave, Inc. SEC Filing

CRWV (CRWV) insiders file Form 144 for 12,500-share sale and detail 10b5-1 trades

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CRWV insiders filed a Form 144 to sell restricted common stock. The filing lists a proposed sale of 12,500 shares of common stock with an aggregate value of $1,111,000.00 through Morgan Stanley Smith Barney LLC Executive Financial Services, with the securities to be sold on 07/13/2026 on NASDAQ. The shares are identified as Founders Shares originally acquired on 02/25/2019 from the issuer.

The disclosure also details extensive Rule 10b5-1 sales of CRWV common stock over the past three months by Brannin McBee, Meghan Bennett and several related trusts and entities, including multiple transactions of 144,000 shares for Brannin McBee and 200,000-share sales in April 2026, with individual transaction proceeds reaching into the tens of millions of dollars.

Positive

  • None.

Negative

  • None.
Shares proposed for sale 12,500 shares Common stock to be sold through Morgan Stanley Smith Barney LLC on 07/13/2026
Proposed sale value $1,111,000.00 Aggregate dollar amount for 12,500 founders’ shares of common stock
Brannin McBee 10b5-1 sale 07/06/2026 144,000 shares; $12,402,648.00 Rule 10b5-1 sale of CRWV common stock on 07/06/2026
Brannin McBee 10b5-1 sale 06/29/2026 144,000 shares; $13,582,699.20 Rule 10b5-1 sale of CRWV common stock on 06/29/2026
Brannin McBee 10b5-1 sale 04/27/2026 200,000 shares; $21,806,780.00 Rule 10b5-1 sale of CRWV common stock on 04/27/2026
Brannin McBee 10b5-1 sale 04/20/2026 200,000 shares; $23,186,400.00 Rule 10b5-1 sale of CRWV common stock on 04/20/2026
Meghan Bennett 10b5-1 sale 07/06/2026 25,000 shares; $2,153,237.50 Rule 10b5-1 sale of CRWV common stock on 07/06/2026
Form 144 regulatory
"Filer Information | | | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Rule 10b5-1 regulatory
"10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave."
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Founders Shares financial
"Common | 02/25/2019 | Founders Shares | Issuer |"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
GRAT financial
"CANIS MAJOR 2025 GRAT 290 W Mt. Pleasant Ave."
Irrevocable Trust financial
"CANIS MAJOR 2024 IRREVOCABLE TR LLC 290 W Mt. Pleasant Ave."
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

What does the CRWV Form 144 filing disclose?
The Form 144 for CRWV discloses a planned sale of 12,500 common shares valued at $1,111,000.00, plus a detailed history of recent Rule 10b5-1 sales by insiders and related entities over the past three months.

How many CRWV shares are proposed for sale under this Form 144?
The filing lists a proposed sale of 12,500 shares of CRWV common stock. These shares, described as Founders Shares, are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on 07/13/2026 on NASDAQ.

What is the aggregate value of the CRWV shares to be sold?
The aggregate value of the 12,500 CRWV common shares proposed for sale is $1,111,000.00. This amount reflects the total dollar value associated with the planned disposition reported in the Form 144 filing.

Who are the main insiders selling CRWV stock in recent 10b5-1 trades?
Recent Rule 10b5-1 sales of CRWV common stock involve Brannin McBee, Meghan Bennett, and related entities such as CANIS MAJOR 2025 GRAT and BRANNIN J. MCBEE 2022 IRR TRUST, with multiple large transactions recorded in April–July 2026.

What are some of the larger recent CRWV insider sales reported?
Larger reported transactions include 200,000 CRWV shares sold by Brannin McBee on 04/20/2026 for $23,186,400.00 and another 200,000-share sale on 04/27/2026 for $21,806,780.00, along with repeated 144,000-share sales in June and July 2026.

How were the CRWV founders’ shares originally acquired?
The Founders Shares referenced in the CRWV Form 144 were acquired on 02/25/2019 from the issuer. The filing identifies them as common stock now being partially sold in the proposed 12,500-share transaction.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR